EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Weight Drop-Foot Drop: A Case Series of Peroneal Nerve Palsy from Leg Crossing after Tirzepatide-Mediated Weight Loss

Ann I Tanyous, Jacob Oren Levitt

Case Reports in Neurology · 08.06.2026 · 18 (1) · 364-369

DOI: 10.1159/000552890 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Neurology, online erschienen am 08.06.2026. Verfasst von Ann I Tanyous und 1 weiteren Autor:innen. Beteiligte Einrichtung: Touro College of Osteopathic Medicine, Middletown, NY, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Common peroneal nerve palsy, termed “slimmer’s palsy,” is a recognized complication of rapid weight loss. This case series describes 2 patients who developed foot drop following tirzepatide-induced weight loss precipitated by habitual leg crossing. Case Presentations: Peroneal neuropathy secondary to compression from habitual leg crossing developed in 2 male patients during tirzepatide therapy for weight loss. Patient 1 was a 55-year-old with severe hidradenitis suppurativa on multiple immunosuppressive medications who started on tirzepatide and lost 50 pounds over 5 months. Patient 2 was a 71-year-old with insulin resistance who lost 30 pounds over 3 months on tirzepatide. Both patients developed foot drop over 24–72 h. Treatment was behavioral modification to avoid leg crossing, supplemented by physical therapy, and, in patient 1, ankle bracing. Foot drop signs resolved over 3 to 4 months.

Conclusion

Clinicians prescribing tirzepatide should counsel patients about peroneal nerve palsy risk during rapid weight loss. Patients should avoid prolonged leg crossing. Early recognition enables timely intervention and favorable outcomes.

Schlagwörter

Stichwörter der Autor:innen

Common peroneal nerve palsyFibular neuropathyFoot dropGLP-1 receptor agonistLeg crossing

Autor:innen und Institutionen

  • Touro College of Osteopathic Medicine, Middletown, NY, USA.
  • Department of Dermatology at The Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Zitieren

APA

Tanyous, A. I., & Levitt, J. O. (2026). Weight Drop-Foot Drop: A Case Series of Peroneal Nerve Palsy from Leg Crossing after Tirzepatide-Mediated Weight Loss. Case Reports in Neurology, 18(1), 364-369. https://doi.org/10.1159/000552890

Vancouver

Tanyous AI, Levitt JO. Weight Drop-Foot Drop: A Case Series of Peroneal Nerve Palsy from Leg Crossing after Tirzepatide-Mediated Weight Loss. Case Reports in Neurology. 2026;18(1):364-369. doi:10.1159/000552890

BibTeX
@article{Tanyous2026,
  author = {Tanyous, Ann I and Levitt, Jacob Oren},
  title = {Weight Drop-Foot Drop: A Case Series of Peroneal Nerve Palsy from Leg Crossing after Tirzepatide-Mediated Weight Loss},
  journal = {Case Reports in Neurology},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {364--369},
  doi = {10.1159/000552890}
}
Kostenlos starten →